Field Detection of Multiple Infectious Diseases with Naked Eye Using Plasmonic-Enhanced Fluorescent Nanoparticles
Accurately diagnosing infectious diseases in a resource-limited setting is a major challenge. Plasmonic materials, via localized surface plasmon resonance (LSPR), have greatly enhanced fluorescence signal and detection sensitivity. However, traditional plasmonic-enhanced fluorescence methods largely rely on near-infrared or visible-light fluorophores with small Stokes shift, limiting naked-eye visibility without filters. In this study, we developed a novel plasmonic silver film (pSilverF) to enhance visible-light fluorescence with large Stokes shift, allowing for improved biomarker detection sensitivity under naked-eye observation. Integrated with bright fluorescent nanoparticles, we designed a multiplexed assay for detecting Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Human Immunodeficiency Virus (HIV) antibodies, achieving detection sensitivities down to 0.0032, 0.023, and 0.168 NCU/mL, respectively. In a cohort of 68 clinical samples, our method achieved 100% sensitivity and specificity for HIV and HCV detection and 96% sensitivity and 100% specificity for HBV detection. Notably, the results can be visualized by the naked eye and directly captured by a standard mobile phone camera without any modification for signal analysis using RGB image splitting. This platform demonstrated potential for field detection of multiple infectious diseases with simple settings, providing a useful tool for disease control in communities and areas with limited medical resources.
Authors
- Rongrong Zou (ORCID: https://orcid.org/0000-0001-5902-8057)
- Pan‐Lin Shao (ORCID: https://orcid.org/0000-0001-7415-2195)
- Cheng Li (ORCID: https://orcid.org/0000-0002-9252-2097)
- Xuan Ning Sharon Tan (ORCID: https://orcid.org/0009-0001-7223-3298)
- Ruibin Hu
- Jingkai Yang
- Jiahui Lv (ORCID: https://orcid.org/0000-0003-2822-7023)
- HongJun Xiao
- Jing Yuan (ORCID: https://orcid.org/0000-0002-8937-9568)
- Ziyi Xu
- Ziqi Jin (ORCID: https://orcid.org/0000-0002-7233-5251)
- Bo Zhang (ORCID: https://orcid.org/0000-0001-8745-2752)
- Jiaxin Li (ORCID: https://orcid.org/0000-0002-1681-3271)
- Ying Liu (ORCID: https://orcid.org/0000-0001-6016-3184)
- Shiyu Chen (ORCID: https://orcid.org/0000-0001-6578-561X)
- Yun He (ORCID: https://orcid.org/0000-0003-1145-3833)
- Xiaohe Li (ORCID: https://orcid.org/0000-0003-3964-704X)
- Zexi Tang
Institutions
- Target (United States) (US)
- Southern University of Science and Technology (CN)
- Key Laboratory of Guangdong Province (CN)
- National Clinical Research (US)
- State Key Laboratory of Respiratory Disease (CN)
- Shenzhen Third People’s Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Analytical Chemistry
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1021/acs.analchem.4c07106
- Citations
- 3
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality